[1] |
Lagos-Quintana M,Rauhut R,Lendeckel W,et al.Identification of novel genes coding for small expressed RNAs[J].Science,2001,294(5543):853-858.
|
[2] |
Kriegel AJ, Liu Y, Fang Y, et al.The miR-29 family:genomics, cell biology,and relevance to renal and cardiovascular injury[J].Physiol Genomics,2012,44(4):237-244.
|
[3] |
Luna C, Li G, Qiu J, et al.Cross-talk between miR-29 and transforming growth factor-betas in trabecular meshwork cells[J].Invest Ophthalmol Vis Sci,2011,52(6):3567-3572.
|
[4] |
Wang H, Garzon R, Sun H, et al.NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma[J].Cancer Cell,2008,14(5):369-381.
|
[5] |
Van der Auwera I, Limame R, van Dam P, et al.Integrated miRNA and mRNA expression profiling of the inflammatory breast cancer subtype[J].Br J Cancer,2010,103(4):532-541.
|
[6] |
Iorio MV, Ferracin M, Liu CG, et al.MicroRNA gene expression deregulation in human breast cancer[J].Cancer Res,2005,65(16):7065-7070.
|
[7] |
Wang C,Bian Z,Wei D,et al.miR-29b regulates migration of human breast cancer cells[J].Mol Cell Biochem,2011,352(1-2):197-207.
|
[8] |
Gebeshuber CA, Zatloukal K, Martinez J.miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis[J].EMBO Rep,2009,10(4):400-405.
|
[9] |
Cittelly DM, Finlay-Schultz J, Howe EN, et al.Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4[J].Oncogene,2012,32(20):2555-2564.
|
[10] |
Buffa FM, Camps C, Winchester L, et al.microRNAassociated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancer[J].Cancer Res, 2011,71(17):5635-5645.
|
[11] |
White NM, Fatoohi E, Metias M, et al.Metastamirs: a stepping stone towards improved cancer management[J].Nat Rev Clin Oncol,2011,8(2):75-84.
|
[12] |
Cochrane DR, Jacobsen BM, Connaghan KD, et al.Progestin regulated miRNAs that mediate progesterone receptor action in breast cancer[J].Mol Cell Endocrinol,2012,355(1):15-24.
|
[13] |
Al-Ahmadi W,Al-Ghamdi M,Al-Souhibani N,et al.miR-29a inhibition normalizes HuR over-expression and aberrant AU-rich mRNA stability in invasive cancer[J].J Pathol,2013,230(1):28-38.
|
[14] |
Wang C, Gao C, Zhuang JL, et al.A combined approach identifies three mRNAs that are down-regulated by microRNA-29b and promote invasion ability in the breast cancer cell line MCF-7[J].J Cancer Res Clin Oncol,2012,138(12):2127-2136.
|
[15] |
Fang JH, Zhou HC, Zeng C, et al.MicroRNA-29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix metalloproteinase 2 expression[J].Hepatology, 2011,54(5):1729-1740.
|
[16] |
Chou J, Lin JH, Brenot A, et al.GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA-29b expression[J].Nat Cell Biol,2013,15(2):201-213.
|
[17] |
Gerson KD, Shearstone JR, Maddula VS, et al.Integrin beta4 regulates SPARC protein to promote invasion[J].J Biol Chem,2012,287(13):9835-9844.
|
[18] |
Li H, Solomon E, Duhachek Muggy S, et al.Metalloproteasedisintegrin ADAM12 expression is regulated by Notch signaling via microRNA-29[J].J Biol Chem,2011,286(24):21500-21510.
|
[19] |
Xiong Y, Fang JH, Yun JP, et al.Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma[J].Hepatology,2010,51(3):836-845.
|
[20] |
Park SY, Lee JH, Ha M, et al.miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42[J].Nat Struct Mol Biol,2009,16(1):23-29.
|
[21] |
Suzuki HI, Yamagata K, Sugimoto K, et al.Modulation of microRNA processing by p53[J].Nature, 2009,460(7254):529-533.
|
[22] |
Fabbri M, Garzon R, Cimmino A, et al.MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B[J].Proc Natl Acad Sci U S A,2007,104(40):15805-15810.
|
[23] |
Nguyen T, Kuo C, Nicholl MB, et al.Downregulation of microRNA-29c is associated with hypermethylation of tumorrelated genes and disease outcome in cutaneous melanoma[J].Epigenetics,2011,6(3):388-394.
|
[24] |
Braconi C, Kogure T, Valeri N, et al.microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer[J].Oncogene, 2011, 30(47):4750-4756.
|
[25] |
Kojima K, Takata A,Vadnais C,et al.MicroRNA122 is a key regulator of α-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma[J].Nat Commun,2011,2:338.
|
[26] |
Ehrlich M.DNA methylation in cancer: too much, but also too little[J].Oncogene,2002,21(35):5400-5413.
|
[27] |
Liu WR, Shi YH, Peng YF, et al.Epigenetics of hepatocellular carcinoma: a new horizon[J].Chin Med J(Engl),2012,125(13):2349-2360.
|